2. ​How do cell-penetrating peptides traverse the plasma membrane?

Cell-penetrating peptides are short peptides, typically made of about 5–30 amino acids, that are able to enter cells by crossing the plasma membrane. Many of them contain several positively charged amino acids, such as arginine or lysine. Because the outer surface of the cell membrane and many membrane-associated molecules carry negative charges, these positively charged peptides can interact strongly with the cell surface. Importantly, they can often enter cells without causing obvious membrane damage. Some well-known examples of cell-penetrating peptides include TAT, penetratin, and polyarginine peptides.

A particularly useful property of these peptides is that they can carry other molecules into cells. They may be chemically linked to a cargo molecule or mixed with it through electrostatic interactions. The cargo can be very diverse, including DNA, RNA, siRNA, proteins, peptides, nanoparticles, or small-molecule drugs. This is important because many biologically useful molecules cannot cross the cell membrane efficiently on their own, especially if they are large, highly charged, or hydrophilic.

They may enter cells in different ways. In some cases, they can interact directly with the plasma membrane and pass through it directly without the involvement of any active, biological process. In many other cases, especially in living cells exhibiting very active membrane turnover, they are taken up by endocytosis. The exact mechanism depends on the peptide sequence, concentration, cargo, cell type, and experimental conditions.

Independent of which uptake pathway is used, cell-penetrating peptides have to cross a bilayer once so that they reach the cytoplasm. After endocytic uptake, they cross the endosomal membrane in a process called endo-lysosomal escape, while when taken up by direct membrane crossing, they traverse the plasma membrane. 

However, there are still challenges, such as improving cell-type specificity, avoiding degradation, reducing toxicity, escaping from endosomes after uptake, and ensuring that the cargo reaches the correct intracellular target.

The positive charge of cell-penetrating peptides comes into interaction with the dipole potential of the membrane, a several hundred-millivolt, positive potential present inside the lipid bilayer. The dipole potential is due to the preferential orientation of carbonyl and water dipoles on the surface of the membrane. We have shown previously (paper 1, paper 2) that reduction of the dipole potential can enhance the cellular uptake of cell-penetrating peptides.



In our current projects, we are trying to optimize the structure of cell-penetrating peptides to deliver biologically relevant cargo to cells more efficiently. We are conjugating cell-penetrating peptides with sequences equipping them with cell specificity as well as extracellular matrix-penetrating potential. 

5. The biophysics of fluorescently-labeled antibodies

Fluorescently-labeled antibodies are widely used in cell biology due to their ease of application and affordability. Although it has been known for quite some time that the labeling procedure negatively impacts the fluorescence properties of dyes and the affinity of the antibody, these shortcomings are mainly important for those only who would like to evaluate fluorescence intensities quantitatively. Since we belong to this group of researchers, we have been studying this phenomenon in the past years.

  • We showed that the degree of labeling (DOL) of cell-bound antibodies is often lower than the DOL measured in the antibody stock, in some cases leveling off at about two fluorophores per IgG, meaning that highly labeled antibody species bind cells less efficiently. Using Alexa Fluor 546 and Alexa Fluor 647 conjugates, we showed that increasing labeling can both reduce antibody affinity and alter dye photophysics, including self-quenching; Alexa Fluor 546 was more strongly affected in quantum yield, whereas Alexa Fluor 647 more strongly impaired antibody affinity. Overall, the study warns that fluorescence intensity from labeled antibodies is not simply proportional to antibody amount, so quantitative cell-biological measurements must account for labeling-dependent changes in binding and brightness.  (https://doi.org/10.1016/j.bpj.2017.12.011).
  • We showed that fluorescent dye conjugation can cause a global structural and dynamic rearrangement of IgG antibodies, not merely a local disturbance near the labeled lysines. As the degree of labeling increased, several independent antibody functions declined in a similar way, including antigen/epitope binding, protein A/G binding, Fcγ receptor binding, and anti-Fc antibody recognition, suggesting that the whole antibody architecture is affected. This conclusion was supported by biophysical experiments and simulations showing faster nanosecond-scale dynamics, reduced distances between Fc and hypervariable regions by FRET, and a likely hydrophobic-effect-driven collapse of antibody structure (see animations and the model).(https://doi.org/10.1016/j.ijbiomac.2025.146209).

Our current efforts are aimed at elucidating what kind of local properties govern which sites are labeled in the antibodies.